inewsmagazine

Small Business

CMS asks pharmacies how Medicare drug plans set contract terms before writing the first federal standards

A 2026 law requires federal standards for drug plans' pharmacy contracts from 2029. CMS asks how plans pay and audit pharmacies; comments close November 23.

By Small Business Desk ·

The short version

  1. The Consolidated Appropriations Act, 2026, requires the terms Medicare Part D plans offer network pharmacies to be reasonable and relevant under federal standards from 2029.
  2. CMS's request for information, published September 24, 2026, asks about payment, dispensing fees, price lists, audits, deemed acceptance and disputes. Comments close November 23.
  3. The SBA's Office of Advocacy flagged the request to small entities on November 9 and told them to comment before the deadline.
  4. The request sets no rules. The standards are due by the first Monday in April 2028, for plan years starting on or after January 1, 2029.

Pharmacies that fill prescriptions for Medicare patients have until November 23 to tell the Centers for Medicare & Medicaid Services how drug plans treat them in contracts. The Small Business Administration's Office of Advocacy, which represents small businesses' views within the executive branch, flagged the request on November 9, 2026, and told small entities to read it and comment before the deadline. CMS published the request for information in the Federal Register on September 24, 2026, as the first step toward federal standards for the terms Medicare Part D plans offer the pharmacies in their networks.

The request comes from section 6223(a) of the Consolidated Appropriations Act, 2026. It requires Part D plan sponsors to let any pharmacy that meets their standard contract terms join their networks, and requires those terms to be "reasonable and relevant" under standards set by the Secretary of Health and Human Services, for plan years beginning on or after January 1, 2029. The law gave the Secretary until April 1, 2027, to issue a request for information and until the first Monday in April 2028, which by our count is April 3, to set the standards.

Current Part D rules already require plans to contract with any pharmacy that meets their standard terms, and say those terms must be reasonable and relevant. But CMS says it has not set further requirements for what that means. In a 2005 rule it allowed terms to vary by region or type of pharmacy, as long as all similarly situated pharmacies are offered the same terms.

Steps toward federal standards for Part D pharmacy contracts, from CMS's request for information and the Office of Advocacy
DateStep
January 28, 2005Part D final rule: standard terms may vary by area or pharmacy type if similarly situated pharmacies get the same terms
September 24, 2026CMS publishes its request for information (file code CMS-4217-NC)
November 9, 2026SBA Office of Advocacy alerts small entities
November 23, 2026Comment deadline
April 1, 2027Legal deadline for the request for information (met by the September notice)
April 3, 2028Deadline for the standards (the first Monday in April 2028, our count)
January 1, 2029Standards apply to plan years starting on or after this date

What CMS wants to know

Most of the questions are about money. CMS asks whether plan payments and dispensing fees cover pharmacies' drug and operating costs, how plans set and update their maximum allowable cost price lists, and how far the price shown when a claim is processed differs from what a pharmacy ends up receiving after year-end reconciliations under aggregate guarantees such as generic and brand effective rates. It asks whether payment rates are linked to pharmacy deserts in rural, urban or other underserved areas, and whether CMS itself should set reimbursement methods or rates as part of the standards.

Other questions cover the contracting process: how long pharmacies get to review terms, clauses that treat silence as acceptance, changes to terms or price lists in the middle of a contract, and how disputes are settled. CMS also asks about audits, including recoupments over minor errors and the use of extrapolation, and about quality measures that may weigh more heavily on some pharmacies, citing size, setting and non-chain status as examples.

Bargaining power and pharmacy types

Several questions go to bargaining power. CMS asks about the relative leverage of plan sponsors, pharmacy benefit managers and pharmacies, how it varies by pharmacy type and location, and the role of pharmacy services administrative organizations in contract talks. It also asks about vertical integration, which it defines as control of insurance plans, pharmacy benefit managers and pharmacies within one corporate structure, and whether specialty pharmacy networks overlap with common ownership between a benefit manager and its own specialty pharmacy.

Advocacy's remit covers businesses with fewer than 500 employees, non-profit organizations and independent contractors. CMS suggests respondents take account of factors such as the type of pharmacy, from retail and mail order to home infusion, long-term care, specialty, compounding and Indian Health Service, tribal and urban Indian pharmacies, and whether it is in a rural or urban area.

What happens next

The request sets no rules. CMS says it is "issued solely for information and planning purposes" and that it will consider the input as it develops future proposals or guidance. It also asks how the standards would overlap with separate disclosure requirements and remuneration restrictions for pharmacy benefit managers in the Social Security Act. Comments go to docket CMS-2026-3037 on regulations.gov, or by mail, citing file code CMS-4217-NC, according to the Federal Register record and the notice. CMS warns that it posts comments publicly, including any personal or confidential business information they contain.

Sources

  1. Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards (91 FR 60568, FR Doc. 2026-19535) Centers for Medicare & Medicaid Services, via the U.S. Government Publishing Office (govinfo), September 24, 2026
  2. CMS Requests Information on Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards U.S. Small Business Administration, Office of Advocacy, November 9, 2026
  3. Federal Register API record for FR Doc. 2026-19535 (comments close 2026-11-23, docket CMS-4217-NC) Office of the Federal Register, November 12, 2026

Researched and drafted with AI assistance, then checked against the 3 sources above in a separate fact-check on November 12, 2026. Spotted an error? Tell us.

Read next

  1. Small Business

    SBA streamlines its surety bond guarantees for small contractors in a final rule effective January 15

    The rule, published November 16, ends per-application signatures, allows 60 days to pay SBA's fee and moves Quick Bond limits out of the regulations.

    · 4 min read

  2. Small Business · Explainer

    NIST's new cybersecurity guide for one-person businesses: what it covers and what changed since 2016

    Published November 2, the free NIST guide maps its Cybersecurity Framework onto firms with no employees, with worksheets and three sample businesses.

    · 4 min read

  3. Small Business · Explainer

    New Opportunity Zones start on January 1: what changes for businesses in the old and new zones

    6,576 census tracts become Opportunity Zones on January 1, 2027. IRS guidance says property bought later for zones not on the new list generally won't qualify.

    · 5 min read